SPH5030

• CAT Number: I042928
• CAS Number: 2364326-23-6
• Molecular Formula: C31H31FN8O3
• Molecular Weight: 582.63
• Purity: ≥95%
• Synonyms: (Z)-N-[7-ethoxy-4-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]quinazolin-6-yl]-2-fluoro-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide
• InChI: InChI=1S/C31H31FN8O3/c1-4-42-28-16-25-23(15-26(28)38-31(41)24(32)13-21-6-5-10-39(21)3)30(35-17-33-25)37-20-7-8-27(19(2)12-20)43-22-9-11-40-29(14-22)34-18-36-40/h7-9,11-18,21H,4-6,10H2,1-3H3,(H,38,41)(H,33,35,37)/b24-13-/t21-/m1/s1
• InChIKey: HTAMCULFUCGZAM-FKYOTISTSA-N
• SMILES: CCOC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)OC4=CC5=NC=NN5C=C4)C)NC(=O)/C(=C/[C@H]6CCCN6C)/F

SPH5030（Cat No.:I042928）is a selective small molecule compound designed to target specific signaling pathways involved in cancer and other diseases. It works by inhibiting key proteins or enzymes that regulate cell growth, survival, and proliferation, which are often dysregulated in tumors. SPH5030 has shown potential in preclinical studies for its ability to reduce tumor growth and improve the efficacy of existing cancer therapies. Researchers are investigating its therapeutic applications in oncology, with a focus on enhancing targeted treatments and overcoming resistance mechanisms commonly seen in cancer cells.